Lacto-ovo-vegetarian Diet Riched in Omega-3 Fatty Acids in Menopausal Women
NCT02816814 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2016-06-30
Summary
Healthy lifestyle, based on healthy diet and exercise, is a key factor to prevent the most common menopausal disorders and chronic diseases to which women are more exposed during this life stage. Therefore, menopausal women may represent a target for evaluating the effectiveness of nutritional intervention studies based on protective diets against the common metabolic diseases, such as metabolic syndrome, obesity and hepatic steatosis.
Lipidomics aims to study the lipid molecules in a "dynamic" way and allows to define not only structure and functions of a set of lipid species present in an organism, but also the changes that occur during cell metabolism under physiological and pathological conditions in order to understand their role as part of the complex functional balance of a living organism.
Quantitative and qualitative determination of fatty acids profiles in cell membranes allows to follow their molecular changes occurring for intrinsic and extrinsic metabolic causes, such as inflammation, stress, nutrition.
Scientific evidence has shown that, for nutritional studies, the most representative cell is the erythrocyte, which is a biomarker of an individual's general state of health. In fact, the evaluation of the fatty acid composition contained in the membrane of red blood cell, which has an half-life of four months, allows to follow the nutritional status of a subject and to acquire information about his eating habits, with special reference to fat consumption.
The higher intake of omega-3 fatty acids is associated with a decreased inflammatory state which is often altered in patients with metabolic diseases, hepatic steatosis and obesity.
Overweight or obese women in menopause for at least 12 months, aged between 45 and 68 years, will be submitted at baseline to blood samples for lipidomic profile, blood tests, medical examination with blood pressure and anthropometric measurements (weight, height, waist and hip circumferences), indirect calorimetry and bioimpedentiometry. Participants will be randomly assigned to diet with extra virgin olive oil (LoVE DIET) or to diet riched in omega-3 fatty acids (LωVE DIET) for four months. During the treatment period, women enrolled will undergo medical examination and dietary control to assess the adherence to the dietary pattern, collecting anthropometric measurements, indirect calorimetry and bioimpedentiometry after 4 and 16 weeks as well as blood samples after 16 weeks.
The results will be analyzed using appropriate statistical tests. All patients will be made to sign an informed consent.
Conditions
- Menopause
- Metabolic Syndrome
- Hepatic Steatosis
Interventions
- OTHER
-
Diet rich in omega-3 fatty acids
A diet rich in omega-3 fatty acids (7g/die) will be administered for 4 months to overwieght women in menopause
- OTHER
-
Diet with extra virgin olive oil
A diet rich in EVO (25-30g/die) will be administered for 4 months to overwieght women in menopause
Sponsors & Collaborators
-
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Max Age
- 68 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2017-06-30
- Completion
- 2018-06-30
Countries
- Italy
Study Locations
More Related Trials
-
Metabolic Actions of Omega-3 Fatty Acids
NCT01896414 ·Status: COMPLETED ·Phase: NA
-
Effect of Omega-3 PUFA Supplementation in NAFLD Patients
NCT00230113 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women.
NCT00599456 ·Status: COMPLETED ·Phase: NA
-
Effect of a Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and Endothelial Progenitor Cells (EPC's)
NCT00166088 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of an Optimized Formulation of Omega 3 on the Composition of Atheromatous Plaques in Patients Requiring Carotid Endarterectomy
NCT02582710 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women
NCT01894581 ·Status: COMPLETED ·Phase: NA
-
Does Consuming Modified Plant Seed Oil Containing Fish Oil Fatty Acids Act in the Same Way as Consuming Fish Oil?
NCT03477045 ·Status: COMPLETED ·Phase: NA
-
Omega 7 + 3 Combination and Systemic Inflammation
NCT02155816 ·Status: COMPLETED ·Phase: NA
-
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
NCT02923804 ·Status: COMPLETED ·Phase: NA
-
The Optimum Omega-3 (003) Diet Study
NCT01642368 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Nutritional Status of Omega-3 Fatty Acids and the Possible Influences of Dietary Patterns and Different Socioeconomic Factors, in a Spanish Population Over 60 Years of Age
NCT06916455 ·Status: RECRUITING
-
Efficacy and Safety of a Fish Oil Containing Lipid Emulsion
NCT01176695 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Omega-3 Fatty Acid on Endothelial Function
NCT01813006 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Probiotic Co-administration With Omega-3 Fatty Acids on NAFLD
NCT03528707 ·Status: COMPLETED ·Phase: NA
-
Effect of Fish Oil on Adiposity and Atherogenic Factors in Type 2 Diabetic Women
NCT00371982 ·Status: TERMINATED ·Phase: NA
-
Study of Metabolic Syndrome Use Omega-3 Fatty Acids and Low Fat Meal
NCT01768169 ·Status: UNKNOWN
-
Effects of Omega-3 Fatty Acids on the Human Gene Expression
NCT01089231 ·Status: COMPLETED ·Phase: PHASE4
-
Olive Oil and Nampt on Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic Syndrome
NCT02061267 ·Status: COMPLETED ·Phase: NA
-
Nutrition and Pregnancy Intervention Study
NCT01922791 ·Status: COMPLETED ·Phase: NA
-
Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors
NCT02150525 ·Status: COMPLETED ·Phase: PHASE2
-
Fish Oil and Cardiovascular Suboptimal Health
NCT02103517 ·Status: COMPLETED ·Phase: PHASE3
-
Genotype-related Effects of PUFA
NCT02296385 ·Status: COMPLETED ·Phase: NA
-
Hot Flashes and Omega 3
NCT02062528 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids and Insulin Sensitivity
NCT01686568 ·Status: COMPLETED ·Phase: PHASE3
-
Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides
NCT02625870 ·Status: UNKNOWN ·Phase: PHASE3